<p>
Britain on Thursday became the first country in the world to approve a potentially game-changing antiviral pill to treat COVID-19, jointly developed by U.S. pharma companies Merck and Ridgeback Biotherapeutics.</p>
<p>
Britain&#39;s Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.</p>
<p>
The tablet will be given twice a day for five days to vulnerable patients recently diagnosed with the disease.</p>
<p>
In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.</p>
<p>
It is the first antiviral medication for Covid which can be taken as a pill rather than injected or given intravenously.</p>
<p>
The UK has agreed to purchase 480,000 courses with the first deliveries expected in November, according to a BBC report.</p>
<p>
It cited UK Health Secretary Sajid Javid as saying the treatment was a &quot;gamechanger&quot; for the most frail and immunosuppressed.</p>
<p>
In a statement he said: &quot;Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid.&quot;</p>
<p>
This is the first oral antiviral treatment for COVID-19 to get approved, with the approval coming ahead of potential U.S. regulatory clearance. U.S. advisers will meet this month to vote on whether molnupiravir should be authorized.</p>
<p>
The drug, to be branded Lagevrio in Britain, is designed to introduce errors into the genetic code of the virus that causes COVID-19.</p>
<p>
The speedy approval in Britain comes as the country has about 40,000 daily cases of COVID-19, according to the latest seven-day average. That total is second only to the roughly 74,000 a day in the United States, which has a five times larger population.</p>
<p>
<strong>Also read: <a href="https://www.indianarrative.com/health-news/who-approves-india-s-homegrown-vaccine-covaxin-for-emergency-use-125864.html">WHO approves India&rsquo;s homegrown vaccine Covaxin for emergency use</a></strong></p>
Jamil Maqsood, the President of the Foreign Affairs Committee of the United Kashmir People's National…
The 6th meeting of the ASEAN-India Trade in Goods Agreement (AITIGA) Joint Committee concluded in…
The US Department of Homeland Security (DHS), on behalf of the Forced Labor Enforcement Task…
A delegation from the Tibetan Parliament-in-Exile (TPiE), led by Speaker Khenpo Sonam Tenphel and accompanied…
On the sidelines of the 2nd India-CARICOM Summit, leaders of the member countries witnessed a…
India's economic growth story has witnessed a remarkable surge in investment spending, with over half…